Florian J. Fintelmann

As the head of Thoracic Imaging Percutaneous Thermal Ablation at Massachusetts General Hospital, Dr. Fintelmann is integrated into the Thoracic Cancer Team. His research focuses on improving cancer care with quantitative image analysis, machine learning, and image-guided minimally invasive interventions.

Dr. Fintelmann studies lung cancer from early diagnosis (lung cancer screening with low-dose chest computed tomography) to advanced disease. As a Thoracic Interventional Oncologist, Dr. Fintelmann believes that patients with cancer benefit from minimally invasive image-guided diagnostic and therapeutic procedures. He is studying percutaneous thermal ablation (cryoablation, microwave ablation) and needle biopsies in patients with lung cancer and lung metastases. Dr. Fintelmann advocates for percutaneous thermal ablation to treat lung cancer in patients with interstitial lung disease and recurrent lung cancer following radiation therapy. Clinical trials in collaboration with the MGH Cancer Center investigate possible synergy between immunotherapy and cryoablation in patients with advanced lung cancer and advanced melanoma (cryoimmunotherapy, cryoimmunology).

Dr. Fintelmann leads a multi-disciplinary team studying cancer cachexia. He is using quantitative image analysis to improve the risk stratification of patients with cancer for appropriate therapies. His lab is leveraging machine learning to extract morphomic data such as body composition from computed tomography exams of the chest and abdomen obtained as part of routine clinical care.